The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Modulators Of Pharmacokinetic Properties Of Therapeutics - EP3150586

The patent EP3150586 was granted to Gilead Sciences on Jan 8, 2020. The application was originally filed on Feb 22, 2008 under application number EP16180589A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3150586

GILEAD SCIENCES
Application Number
EP16180589A
Filing Date
Feb 22, 2008
Status
Granted And Under Opposition
Dec 6, 2019
Publication Date
Jan 8, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

COOKEOct 8, 2020ELKINGTON AND FIFEADMISSIBLE
TEVA PHARMACEUTICALSOct 6, 2020EDERADMISSIBLE
STADA ARZNEIMITTELJan 10, 2020HAMM & WITTKOPPADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2008010921
OPPOSITIONEP1183026
OPPOSITIONWO2005039551
OPPOSITIONWO2008010921
OPPOSITIONWO9701349
SEARCHEP1183026
SEARCHWO2008010921
SEARCHWO9701349

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents